Postnatal steroids in preterm neonates

Italian Journal of Pediatrics

Volumn 28, Issue 1, 2002, Pages 24-28

  Grier, David G ^a   Halliday, H L ^b  

^a ROYAL MATERNITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Corticosteroids; Neonate; Preterm

Indexed keywords

BETAMETHASONE; BUDESONIDE; DEXAMETHASONE; HYDROCORTISONE; SURFACTANT;

ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CORTICOSTEROID THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; INCIDENCE; LUNG DYSPLASIA; LUNG INJURY; MORBIDITY; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NEWBORN INTENSIVE CARE; PATHOGENESIS; PREMATURITY; REVIEW; SURVIVAL;

EID: 0036488664     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-68.
2. Corcoran JD, Patterson CC, Thomas PS, Halliday HL. Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis. Eur J Pediatr 1993;152:677-81.
3. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992;90:663-8.
4. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1983;i:1356-8.
5. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-11.
6. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:E7, (http://www.pediatrics.org/cgi/content/ full/101/5/e7).
7. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-81.
8. Sweet DG, Halliday HL. A risk-benefit assessment of drugs used for neonatal chronic lung disease. Drug Saf 2000;22:389-404.
9. Jobe AH. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3.
10. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998;94:557-72.
11. Groneck P, Reuss D, Gotze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993;122:938-44.
12. Baden M, Bauer CR, Colle E, Klein G, Taeusch HW, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 1972;50:526-34.
13. Taeusch HW Jr, Wang NS, Baden N, Bauer CR, Stem L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome: II. Pathology. Pediatrics 1973;52:850-4.
14. Ewerbeck H, Helwig H, Reynolds JW, Provenzano RW. Treatment of idiopathic respiratory distress with large doses of corticoids. Pediatrics 1972;49:467-8.
15. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990;117:273-82.
16. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994;36:122-8.
17. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992;120:286-91.
18. Halliday HL, Ehrenkranz RA. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library. Issue 3, 2001. Oxford: Update Software.
19. Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
20. Halliday HL, Ehrenkranz RA. Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
21. Barrington JK. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatrics 2001;1:1 (http://www.biomedcentral.com/1471-2431/1/1).
22. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 1998;338:1112-8.
23. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001;344:95-101.
24. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-21.
25. The Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 2001;108:741-8.
26. Howard H. Reductions in size and total DNA of cerebellum in adult mice after corticosteroid treatment in infancy. Exp Neurol 1968;22:191-208.
27. Weichsel ME. The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Ann Neurol 1977;46:364-6.
28. Tsubota S, Adachi N, Chen J, Yorozuya T, Nagaro T, Arai T. Dexamethasone changes brain monoamine metabolism and aggravates ischemic neuronal damage in rats. Anesthesiology 1999;90:515-23.
29. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res 1990;53:157-67.
30. Diaz R, Fuxe K, Ogren SO. Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 1997;81:129-40.
31. Gandelman R, Rosenthal C. Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice. Teratology 1981;24:293-301.
32. Matthews SG. Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 2000;47:291-300.
33. Halliday HL. Postnatal steroids: a dilemma for the neonatologist. Acta Paediatr 2001;90:116-8.
34. Halliday HL, Patterson CC, Halahakoon CW. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics 2001;107:232-40.
35. Thebaud B, Lacaze-Masmonteil T, Watterberg K. Postnatal glucocorticoids in vety preterm infants: «the good, the bad, and the ugly»? Pediatrics 2001;107:413-5.
36. Andre P, Thebaud B, Odievre MH, Razafimahefa H, Zupan V, Dehan M, et al. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease. Intensive Care Med 2000;26:1496-500.
37. Watterberg KL, Gerdes JS, Gifford KL, Lin HM. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999;104:1258-63.
38. Watterberg KL, Gerdes JS, Cook KL. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 2001;50:190-5.
39. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
40. Baud O. Is perinatal dexamethasone treatment safe in preterm infants? Dev Med Child Neurol Suppl 2001;86:23-5.
41. Shah V, Ohlsson A, Halliday HL, Dunn MS. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
42. Halliday HL. Perinatal corticosteroid treatment - helpful or harmful. Arch Perinatal Med 2000;6:7-9.
43. Doyle L, Davis P. Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. J Paediatr Child Health 2000;36:101-7.